OBJECTIVE: The development of diabetic nephropathy is considered to be associated with oxidative stress. NADPH oxidase and the receptor for advanced glycation end products (RAGE) have attracted attention as mechanisms of generating oxidative stress. We studied the relation between the genotypes of the NADPH p22phox C242T and RAGE G1704T polymorphisms and the development of diabetic nephropathy in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Using a retrospective review of clinical data, we allocated 181 Japanese type 2 diabetic patients to one of two groups: patients without diabetic nephropathy (group N; n = 108) and patients developing diabetic nephropathy (group D; n = 73) for 10 years or more. The p22phox C242T and RAGE G1704T polymorphisms were examined by Taqman PCR methods. RESULTS: The frequency of the p22phox CC genotype was significantly higher in group D than in group N (90 vs. 79%; P = 0.0427). The frequency of the RAGE GT + TT genotype was significantly higher in group D than in group N (26 vs. 13%; P = 0.0313). The frequency of the combination of p22phox CC and RAGE GT + TT genotypes was significantly higher in group D than in group N (22 vs. 8%; P = 0.0057). In multiple logistic regression analysis, systolic blood pressure, HbA(1c), triglycerides, and the combination of polymorphisms were shown to be independent variables. CONCLUSIONS: These results suggest that assessment of the combination of NADPH p22phox C242T and RAGE G1704T polymorphisms may be useful in identifying the risk for developing diabetic nephropathy in type 2 diabetic patients.
OBJECTIVE: The development of diabetic nephropathy is considered to be associated with oxidative stress. NADPH oxidase and the receptor for advanced glycation end products (RAGE) have attracted attention as mechanisms of generating oxidative stress. We studied the relation between the genotypes of the NADPH p22phox C242T and RAGEG1704T polymorphisms and the development of diabetic nephropathy in type 2 diabeticpatients. RESEARCH DESIGN AND METHODS: Using a retrospective review of clinical data, we allocated 181 Japanese type 2 diabeticpatients to one of two groups: patients without diabetic nephropathy (group N; n = 108) and patients developing diabetic nephropathy (group D; n = 73) for 10 years or more. The p22phox C242T and RAGEG1704T polymorphisms were examined by Taqman PCR methods. RESULTS: The frequency of the p22phox CC genotype was significantly higher in group D than in group N (90 vs. 79%; P = 0.0427). The frequency of the RAGE GT + TT genotype was significantly higher in group D than in group N (26 vs. 13%; P = 0.0313). The frequency of the combination of p22phox CC and RAGE GT + TT genotypes was significantly higher in group D than in group N (22 vs. 8%; P = 0.0057). In multiple logistic regression analysis, systolic blood pressure, HbA(1c), triglycerides, and the combination of polymorphisms were shown to be independent variables. CONCLUSIONS: These results suggest that assessment of the combination of NADPH p22phox C242T and RAGEG1704T polymorphisms may be useful in identifying the risk for developing diabetic nephropathy in type 2 diabeticpatients.
Authors: Qing Lan; Tongzhang Zheng; Min Shen; Yawei Zhang; Sophia S Wang; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Peter Boyle; Stephen Chanock Journal: Hum Genet Date: 2006-12-06 Impact factor: 4.132
Authors: Kuo-Jung Ho; Tzu-Hua Chen; Chen-Cheng Yang; Yao-Chung Chuang; Hung-Yi Chuang Journal: Int J Environ Res Public Health Date: 2021-08-06 Impact factor: 3.390
Authors: Malgorzata Gorska-Ciebiada; Malgorzata Saryusz-Wolska; Anna Borkowska; Maciej Ciebiada; Jerzy Loba Journal: Front Aging Neurosci Date: 2015-10-29 Impact factor: 5.750
Authors: Foo Nian Wong; Kek Heng Chua; Umah Rani Kuppusamy; Chew Ming Wong; Soo Kun Lim; Jin Ai Mary Anne Tan Journal: PeerJ Date: 2016-04-18 Impact factor: 2.984